Chris Lavictoire Mahai - SEC Form 4 Insider Trading Activity

Summary

Updated Aug 3, 2026

Chris Lavictoire Mahai has filed 4 SEC Form 4 filings across 4 companies in the last 90 days - buying. Lifetime open-market purchases: $42K.

Profile

Chris Lavictoire Mahai holds the role of Director at abrdn Life Sciences Investors (HQL). Mahai's filing history also covers abrdn Healthcare Investors (HQH) and abrdn World Healthcare Fund (THW). Mahai has reported 4 insider filings with the SEC since 2026. The most recent filing was in July 2026.

RoleDirector
Notability26/100

Board memberships

Reported roles

Awards & honors

Trading Pattern

InsiderAlpha's records for Chris Lavictoire Mahai go back to 2026: 4 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $11K (4 buys totaling $42K). The largest single buy on record is $11K of THW in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.

Career & Filing History

Every role Chris Lavictoire Mahai has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-20HQLabrdn Life Sciences InvestorsP - Open-market purchase527$19.92$10K
2026-07-20HQHabrdn Healthcare InvestorsP - Open-market purchase501$20.96$11K
2026-07-20THWabrdn World Healthcare FundP - Open-market purchase796$13.20$11K
2026-07-20THQabrdn Healthcare Opportunities FundP - Open-market purchase568$18.49$11K

Companies - Last 90 Days

Other Insiders Active in the Same Stocks

Insiders who reported open-market trades at the companies Chris Lavictoire Mahai has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.

More Notable Insiders

Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:

Frequently Asked Questions

Who is Chris Lavictoire Mahai?

Chris Lavictoire Mahai holds the role of Director at abrdn Life Sciences Investors (HQL). Mahai's filing history also covers abrdn Healthcare Investors (HQH) and abrdn World Healthcare Fund (THW). Mahai has reported 4 insider filings with the SEC since 2026. The most recent filing was in July 2026.…

How many SEC Form 4 filings has Chris Lavictoire Mahai submitted recently?

4 primary Form 4 filings in the last 90 days, covering 4 companies.

Has Chris Lavictoire Mahai been buying or selling stock?

Recorded transactions: 4 open-market purchases ($42K) and 0 open-market sales across all tracked filings.

Where can I see all of Chris Lavictoire Mahai's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Chris Lavictoire Mahai profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.